- Products
- Reproduction
- Molecular diagnostics
- Careers
- About us
- Contacts
Detection of germline and somatic mutations in BRCA1, BRCA2, PALB2 genes.
NGS DNA panels for the detection of SNV, InDel and CNV somatic variants using AMP technology
NGS RNA panels for the detection of gene fusions, alternative splicing, SNV and InDel variants using AMP technology
Kits for determining the risk of developing cervical cancer using the bisulfite reaction and rtPCR.
Kits for detection of EGFR, KRAS, NRAS, BRAF gene mutations by PNAClamp technology
A kit for the detection of the 6 most frequent mutations of the POLE gene based on the analysis of DNA isolated from FFPE samples using qPCR.
NGS panels for detection of somatic mutations and other genetic biomarkers (incl. TMB, MSI) for comprehensive genomic profiling of solid tumors.
Library prep kit based on 3' mRNA sequencing allowing high resolution to detect virtually every single mRNA molecule present in the cell.
Library preparation kits based on 3' mRNA sequencing for gene expression profiling and other applications.
System for automated multi-marker and multi-gene analysis combining PCR and fragmentation analysis.
The CE-IVD test for early detection of cervical cancer is based on the principle of measuring the methylation status of the PAX1 and JAM3 genes.
The CE-IVD test for early detection of endometrial cancer is based on the principle of measuring the methylation status of the target genes CDO1 and CELF4.
The CE-IVD test for early detection of ovarian cancer is based on the principle of measuring the methylation status of the target genes CDO1 and HOXA9.
NGS panel that captures 127 significantly mutated genes implicated across 12 tumor types.
Panel groups based on amplicon sequencing, which allows detection of low frequency variants (<1%) in key cancer genes.
NGS panels based on amplicon sequencing and patented CleanPlex technology